Take a look at some of Monday's midday movers:
A dog day afternoon for animal health care companies VCAAntech and MWI Veterinary after William Bair was bearish on their upcoming earnings results, noting a warm winter and early start to the flea and tick season that drew sales forward from the latest quarter.
Mead Johnson Nutrition fell after RBC Capital Markets downgraded the stock amid worries over a slowdown in China.
Gilead Sciences moved higher after the FDA approved its Truvada drug to help prevent HIV infection.
Facebook fell below $30 a share for the first time since mid-June on very heavy volume. Evercore’s Ken Sena told CNBC he thinks weakness in Zynga and Groupon has finally spread to Facebook.
Sotheby’s also lost ground after Stephens cut its rating on the auctioneer and lowered its price target. The firm said shares are likely to be “dead money” due to slowdowns in China and Europe.
Par Pharmaceuticals soared after private investment firm TPG agreed to acquire it for $1.8 billion , or $50 a share in cash. The stock is trading above the purchase price as the deal allows Par to look for another offer through August 24th. Other small-cap drug stocks Impax Labs and Hit-Tech Pharmacal also moved higher following the news.Page 1 of 2 | Next Page